Improving psychological distress in parents of children with autism using a new behavioural treatment called Acceptance and Commitment Therapy

ISRCTN ISRCTN17497289
DOI https://doi.org/10.1186/ISRCTN17497289
Submission date
05/05/2021
Registration date
17/05/2021
Last edited
12/04/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Acceptance and Commitment Therapy (ACT) can be useful for improving the psychological well-being of parents of children with Autism Spectrum Disorders (ASD), but until now there is no evidence on the effectiveness of the ACT model with respect to other well-known behavioral treatments. The aim of this study is to assess the effectiveness of ACT compared to the Parent Training (PT) program for parents of children with ASD.

Who can participate?
Parents of children with ASD

What does the study involve?
Parents are randomly allocated to attend 24 weekly meetings lasting 90 minutes each following the ACT protocol or conventional PT. The intervention lasts about 6 months.

What are the possible benefits and risks of participating?
The parent training program may promote psychological positive parenting and reduce the behavioral risk of children. No risks are foreseen.

Where is the study run from?
Research unit in accordance with the Sicilian Region health system (Italy)

When is the study starting and how long is it expected to run for?
December 2017 to December 2020

Who is funding the study?
Sicilian Region (Italy)

Who is the main contact?
Giovanni Pioggia
Giovanni.pioggia@cnr.it

Contact information

Dr Giovanni Pioggia
Scientific

Institute for Biomedical Research and Innovation (IRIB), National Research Council of Italy (CNR)
Messina
98164
Italy

ORCiD logoORCID ID 0000-0002-8089-7449
Phone +39 (0)3203390892
Email giovanni.pioggia@cnr.it

Study information

Study designSingle-center interventional randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleThe effect of Acceptance and Commitment Therapy for improving psychological well-being in parents of individuals with autism spectrum disorders: a randomized controlled trial
Study acronymACT-pA
Study objectivesTo evaluate the effectiveness of the Acceptance and Commitment Therapy (ACT) approach with respect to parental training in reducing psychological distress and improving well-being in parents of autism spectrum disorder (ASD) children.
Ethics approval(s)Approved 02/08/2018, National Research Council (Piazzale Aldo Moro, 7, 00185, Rome, Italy; +39 (0)6 4993/7900; cnr.ethics@cnr.it), ref: 0054444/2018
Health condition(s) or problem(s) studiedPsychological distress in parents of children with autism
InterventionParent pairs are randomly assigned to the experimental group (ACT matrix protocol) or to the control group (Parent Training (PT) protocol) using a computer-generated randomization code.

The interventions consist of 24 weekly meetings lasting 90 minutes each. The total intervention lasts about 6 months.

The experimental group undergo the Acceptance and Commitment Therapy (ACT) protocol. This consists of two intersecting lines that make up four quadrants, which provide a “point of view” on one's psychological actions and experiences. The vertical line is the line of experience, the upper part corresponds to the experience of life linked to the five senses - sight, hearing, taste, smell and touch - (experience of the five senses), the lower part refers to the experiences internal as thoughts and feelings (internal/mental experience). The horizontal line is the behavior line, the left side concerns the actions that perform the function of moving us away from experiences, emotions, unwanted thoughts (experiential avoidance), the right side indicates the actions we take to get closer and go towards our values (committed action).

The control group undergo the Parental Training (PT) protocol. This consists of a training program for parents to teach behavioral management skills for children. The purpose of a parent training program is to promote positive parenting and reduce the behavioral risk of children.
Intervention typeBehavioural
Primary outcome measure1. Psychological flexibility measured using the Acceptance and Action Questionnaire II (AAQ-II) at baseline and 6 months
2. Perception and influence of children's behavior on parent's life measured using Home Situation Questionnaire (HSQ-ASD) at baseline and 6 months
Secondary outcome measures1. Participants' extent of valued living measured using the Valued Living Questionnaire (VLQ) at baseline and 6 months
2. Tendency of an individual to intentional awareness measured using the Mindfulness Attention Awareness Scale (MAAS) at baseline and 6 months
3. Stress level measured using the Parental Stress Index (PSI) at baseline and 6 months
Overall study start date01/12/2017
Completion date01/12/2020

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
SexBoth
Target number of participants66
Total final enrolment20
Key inclusion criteriaParent of child:
1. Between 4 and 10 years of age
2. Clinical diagnosis of ASD based on the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria from a licensed clinical child neuropsychiatric
3. DSM-5 severity scores from mild (level 1) to moderate (level 2) in both social communication and restricted interests and repetitive behaviors domains
4. A verbal and performance Griffiths Mental Development Scales, Extended Revised: 2 to 8 years (GMDS-ER 2-8) and Wechsler Intelligence Scale for Children (WISC-IV) above 70
5. No hearing, visual, or physical disabilities that would prevent participation in the intervention
6. Not being on psychiatric medication
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment01/09/2019
Date of final enrolment01/09/2020

Locations

Countries of recruitment

  • Italy

Study participating centre

Institute for Biomedical Research and Innovation (IRIB), National Research Council
c/o Istituto Marino, root Torre Bianca, Mortelle (ME)
Messina
98164
Italy

Sponsor information

National Research Council
Research council

Aldo Moro Square
Rome
00185
Italy

Phone +39 (0)649937900
Email cnr.ethics@cnr.it
Website https://www.cnr.it/en/ethical-clearance
ROR logo "ROR" https://ror.org/04zaypm56

Funders

Funder type

Government

Sicilian Region of Italy (Assessorato Regionale delle Attività Produttive), grant number n. 08SR2620000204, entitled LAB@HOME - Una Casa Intelligente per l’Autismo, P.O. F.E.S.R. Sicilia 2014/2020

No information available

Results and Publications

Intention to publish date01/07/2021
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Giovanni Pioggia (Giovanni.pioggia@cnr.it).

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 30/06/2021 12/04/2022 Yes No

Editorial Notes

12/04/2022: Publication reference added.
05/05/2021: Trial's existence confirmed by the National Research Council (Italy).